A logo of Baidu is seen at the company's headquarters in Beijing, following the novel coronavirus disease (COVID-19) outbreak, China May 18, 2020. REUTERS/Tingshu Wang

Summary List Placement

Chinese tech company Baidu reportedly plans to raise $2 billion for a biotech startup that will use AI to develop drugs and diagnose diseases. 

Baidu came up with the idea for the startup earlier this year and is currently in talks with investors. The company, which offers internet-related services, is unlikely to be the controlling investor in the startup, people with knowledge of the project told Reuters. 

The startup intends to use Baidu’s AI technology to find and develop drugs, as well as diagnose early-stage cancer, anonymous sources told Reuters. 

Baidu founder and chairman, Robin Li, is directly involved in the startup, which does not yet have a name, the sources said.

The tech firm released a tool earlier this year which analyses the structural information of a virus in 27 seconds, a decrease from 55 minutes, which helps to understand the virus and develop vaccines against COVID-19.

The startup discussions come as governments around the world invest in their healthcare systems and scramble for a coronavirus vaccine. 

As biotech companies developing vaccines are put at the centre of the healthcare industry, 12 biotech venture capital investors at some of the most successful companies in the industry, including ARCH Venture Partners and …read more

Source:: Businessinsider – Technology

      

(Visited 1 times, 1 visits today)

Leave a Reply

Your email address will not be published. Required fields are marked *